Drug metabolism in extrahepatic diseases
- 31 December 1987
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 35 (3) , 375-404
- https://doi.org/10.1016/0163-7258(87)90101-x
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- Treatment with poly I.C. enhances lipid peroxidation and the activity of xanthine oxidase, and decreases hepatic P-450 content and activities in mice and ratsBiochemical and Biophysical Research Communications, 1986
- Induction of xanthine oxidase and depression of cytochrome P-450 by interferon inducers: Genetic difference in the responses of miceBiochemical and Biophysical Research Communications, 1985
- Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducersBiochemical and Biophysical Research Communications, 1984
- Regulation of sexually dimorphic hepatic steroid metabolism by the somatostatin-growth hormone axisJournal of Steroid Biochemistry, 1983
- Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformationBiochemical and Biophysical Research Communications, 1982
- Hepatic cytochrome P-450 in chronically hypoxemic ratsBiochemical and Biophysical Research Communications, 1980
- Selective depression of hepatic cytochrome P-450 hemoprotein by interferon inducersBiochemical and Biophysical Research Communications, 1980
- Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agentsBiochemical and Biophysical Research Communications, 1976
- Decreased theophylline half-life in cigarette smokersLife Sciences, 1975
- Altitude-induced alterations in drug action and metabolismLife Sciences, 1968